BEAM-102

N/A

Report date: 2025/08/14 17:46:51

Base Information

Drug NameBEAM-102

Drug Alias NameBEAM 102BEAM-102

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Gene therapy > Gene editing > Base editing

Mechanisms of ActionGene transferenceHemoglobins modulators

TargetsHemoglobins

Therapy Area/IndicationsAnemia, Sickle Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBeam Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesBeam Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsAnemia, Sickle Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A